Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the Cervix
Clinical trial NCT00031993 · COMPLETED
Trial details
- NCT number
- NCT00031993
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-01
- Primary completion
- 2005-11-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.